BMS-986020, a Specific LPA(1) Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice

Stroke is a leading cause of death. Stroke survivors often suffer from long-term functional disability. This study demonstrated neuroprotective effects of BMS-986020 (BMS), a selective lysophosphatidic acid receptor 1 (LPA(1)) antagonist under clinical trials for lung fibrosis and psoriasis, against...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaire, Bhakta Prasad, Sapkota, Arjun, Choi, Ji Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695306/
https://www.ncbi.nlm.nih.gov/pubmed/33171697
http://dx.doi.org/10.3390/antiox9111097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695306/
https://www.ncbi.nlm.nih.gov/pubmed/33171697
http://dx.doi.org/10.3390/antiox9111097

Ejemplares similares